| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 3 |
| 1 | BLEOMYCIN SULFATE | 2 |
| 2 | METHOTREXATE | 2 |
| 3 | METHOTREXATE SODIUM | 2 |
| 4 | MITOMYCIN | 2 |
| 5 | ASPIRIN | 1 |
| 6 | ASPIRIN 325 MG | 1 |
| 7 | ASPIRIN 81 MG | 1 |
| 8 | BENRALIZUMAB | 1 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MITOMYCIN | 2 | 0.0005 |
| 1 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| 2 | BENRALIZUMAB | 1 | 0.0000 |
| 3 | CISPLATIN | 3 | 0.0000 |
| 4 | FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE | 1 | 0.0000 |
| 5 | FILGRASTIM | 1 | 0.0000 |
| 6 | VENETOCLAX | 1 | 0.0000 |
| 7 | FLUOROURACIL CREAM, 0.5% | 1 | 0.0000 |
| 8 | FLUOROURACIL | 1 | 0.0000 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |
| 1 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 3 | Alkylating Drug [EPC] | 2 | 0.0000 |
| 4 | Leukocyte Growth Factor [EPC] | 1 | 0.0000 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Insulin Analog [EPC] | 1 | 0.0000 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Corticosteroid [EPC] | 1 | 0.0000 |